Biodexa Pharmaceuticals Files 6-K
Ticker: BDRX · Form: 6-K · Filed: May 22, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Biodexa Pharma (fka Midatech) filed a 6-K on 5/22/25, confirming 20-F annual report filing.
AI Summary
Biodexa Pharmaceuticals Plc filed a Form 6-K on May 22, 2025, to report information for the month of May 2025. The filing indicates that the company, formerly known as Midatech Pharma Plc, is a foreign private issuer and files annual reports under Form 20-F. The principal executive office is located in Cardiff, United Kingdom.
Why It Matters
This filing serves as an update for investors regarding Biodexa Pharmaceuticals Plc's reporting status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing confirming reporting status and does not contain new financial or operational information.
Key Players & Entities
- Biodexa Pharmaceuticals Plc (company) — Filer
- Midatech Pharma Plc (company) — Former company name
- May 2025 (date) — Reporting period
- 20250522 (date) — Filing date
- Cardiff, United Kingdom (location) — Principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange on which its securities are traded, or that it has distributed or is required to distribute to its security holders.
What is Biodexa Pharmaceuticals Plc's former name?
Biodexa Pharmaceuticals Plc was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Where is Biodexa Pharmaceuticals Plc's principal executive office located?
The principal executive office of Biodexa Pharmaceuticals Plc is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Does Biodexa Pharmaceuticals Plc file annual reports under Form 20-F?
Yes, the filing indicates by check mark that Biodexa Pharmaceuticals Plc files annual reports under cover of Form 20-F.
What is the SIC code for Biodexa Pharmaceuticals Plc?
The Standard Industrial Classification (SIC) code for Biodexa Pharmaceuticals Plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 22, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).